Jonsson Comprehensive Cancer Center
🇺🇸United States
Development of Liquid Biopsy Technologies for Noninvasive Cancer Diagnostics in Patients With Suspicious Thyroid Nodules or Thyroid Cancer
Suspended
- Conditions
- Interventions
- First Posted Date
- 2021-02-08
- Last Posted Date
- 2024-03-01
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 250
- Registration Number
- NCT04742608
- Locations
- 🇺🇸
UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States
Pembrolizumab for the Treatment of Cervical Intraepithelial Neoplasia
Phase 2
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2021-01-15
- Last Posted Date
- 2024-01-26
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 25
- Registration Number
- NCT04712851
- Locations
- 🇺🇸
University of California at Los Angeles / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States
Cognitive-Behavioral Stress Management Device for the Treatment of Anxiety and Depressive Symptoms in Patients With Stage I-III Breast or Lung Cancer
Not Applicable
Terminated
- Conditions
- Anatomic Stage I Breast Cancer AJCC v8Prognostic Stage IA Breast Cancer AJCC v8Prognostic Stage II Breast Cancer AJCC v8Prognostic Stage III Breast Cancer AJCC v8Prognostic Stage IIIA Breast Cancer AJCC v8Stage IB Lung Cancer AJCC v8Stage IIB Lung Cancer AJCC v8Stage IIIB Lung Cancer AJCC v8Anatomic Stage IIA Breast Cancer AJCC v8Anatomic Stage IIIC Breast Cancer AJCC v8
- Interventions
- First Posted Date
- 2021-01-12
- Last Posted Date
- 2023-07-25
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 5
- Registration Number
- NCT04705025
- Locations
- 🇺🇸
UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States
Short Course Radiation Therapy and Combination Chemotherapy for the Treatment of Stage II-III Rectal Cancer
Phase 1
Recruiting
- Conditions
- Stage III Rectal Cancer AJCC v8Stage IIIB Rectal Cancer AJCC v8Stage IIA Rectal Cancer AJCC v8Stage II Rectal Cancer AJCC v8Stage IIB Rectal Cancer AJCC v8Stage IIIC Rectal Cancer AJCC v8Rectal AdenocarcinomaLocally Advanced Rectal CarcinomaStage IIC Rectal Cancer AJCC v8Stage IIIA Rectal Cancer AJCC v8
- Interventions
- First Posted Date
- 2021-01-11
- Last Posted Date
- 2024-01-18
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 25
- Registration Number
- NCT04703101
- Locations
- 🇺🇸
UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States
Germline DNA-Based Radiosensitivity Biomarker Influence on Toxicity Following Prostate Radiotherapy, GARUDA Trial
Not Applicable
Active, not recruiting
- Conditions
- Interventions
- First Posted Date
- 2020-11-10
- Last Posted Date
- 2024-08-23
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 226
- Registration Number
- NCT04624256
- Locations
- 🇺🇸
UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States
Pamiparib and Temozolomide for the Treatment of Hereditary Leiomyomatosis and Renal Cell Cancer
Phase 2
Withdrawn
- Conditions
- Clear Cell Papillary Renal NeoplasmHereditary Leiomyomatosis and Renal Cell CarcinomaCollecting Duct CarcinomaMetastatic Unclassified Renal Cell CarcinomaPapillary Renal Cell CarcinomaStage III Renal Cell Cancer American Joint Committee on Cancer (AJCC) v8Unresectable Renal Cell CarcinomaHereditary Papillary Renal Cell CarcinomaMetastatic Renal Cell CarcinomaStage IV Renal Cell Cancer AJCC v8
- Interventions
- First Posted Date
- 2020-10-26
- Last Posted Date
- 2023-05-17
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Registration Number
- NCT04603365
Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer
Phase 2
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2020-09-17
- Last Posted Date
- 2023-11-07
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 88
- Registration Number
- NCT04553770
- Locations
- 🇺🇸
St. Joseph Heritage Healthcare, Fullerton, California, United States
🇺🇸Cancer Blood and Specialty Clinic, Los Alamitos, California, United States
🇺🇸UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States
Interstitial Brachytherapy for the Treatment of Unresectable/Unablatable Kidney Cancer
Phase 1
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2020-07-16
- Last Posted Date
- 2024-04-12
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 17
- Registration Number
- NCT04473781
- Locations
- 🇺🇸
UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States
Abemaciclib for the Treatment of Recurrent Ovarian or Endometrial Cancer
- First Posted Date
- 2020-07-14
- Last Posted Date
- 2024-06-07
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 32
- Registration Number
- NCT04469764
- Locations
- 🇺🇸
UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States
68Ga-FAPi-46 PET/CT Scan in Imaging Patients With Sarcoma
Early Phase 1
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2020-07-07
- Last Posted Date
- 2024-07-05
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 30
- Registration Number
- NCT04457258
- Locations
- 🇺🇸
UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States
© Copyright 2024. All Rights Reserved by MedPath